177 related articles for article (PubMed ID: 26879120)
1. Opioid tolerance in methadone maintenance treatment: comparison of methadone and levomethadone in long-term treatment.
Gutwinski S; Schoofs N; Stuke H; Riemer TG; Wiers CE; Bermpohl F
Harm Reduct J; 2016 Feb; 13():7. PubMed ID: 26879120
[TBL] [Abstract][Full Text] [Related]
2. [Methadone and levomethadone - dosage and side effects].
Schoofs N; Riemer T; Bald LK; Heinz A; Gallinat J; Bermpohl F; Gutwinski S
Psychiatr Prax; 2014 Mar; 41(2):82-7. PubMed ID: 24254424
[TBL] [Abstract][Full Text] [Related]
3. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment.
Levine AR; Lundahl LH; Ledgerwood DM; Lisieski M; Rhodes GL; Greenwald MK
J Subst Abuse Treat; 2015 Jul; 54():37-43. PubMed ID: 25795601
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic-pharmacodynamic modeling of mood and withdrawal symptoms in relation to plasma concentrations of methadone in patients undergoing methadone maintenance treatment.
Shiran MR; Lennard MS; Iqbal MZ; Lagundoye O; Seivewright N; Tucker GT; Rostami-Hodjegan A
J Clin Psychopharmacol; 2012 Oct; 32(5):666-71. PubMed ID: 22926601
[TBL] [Abstract][Full Text] [Related]
5. Switching opioid-dependent patients in substitution treatment from racemic methadone, levomethadone and buprenorphine to slow-release oral morphine: Analysis of the switching process in routine care.
Baschirotto C; Lehmann K; Kuhn S; Reimer J; Verthein U
J Pharmacol Sci; 2020 Sep; 144(1):9-15. PubMed ID: 32586692
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action.
Lötsch J; Skarke C; Wieting J; Oertel BG; Schmidt H; Brockmöller J; Geisslinger G
Clin Pharmacol Ther; 2006 Jan; 79(1):72-89. PubMed ID: 16413243
[TBL] [Abstract][Full Text] [Related]
7. A study of 6-year retention in methadone maintenance treatment among opioid-dependent patients in Xi'an.
Wei X; Wang L; Wang X; Li J; Li H; Jia W
J Addict Med; 2013; 7(5):342-8. PubMed ID: 23896752
[TBL] [Abstract][Full Text] [Related]
8. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
White WL; Campbell MD; Spencer RD; Hoffman HA; Crissman B; DuPont RL
J Psychoactive Drugs; 2014; 46(2):114-22. PubMed ID: 25052787
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal patterns of benzodiazepine consumption in a German cohort of methadone maintenance treatment patients.
Specka M; Bonnet U; Heilmann M; Schifano F; Scherbaum N
Hum Psychopharmacol; 2011 Aug; 26(6):404-11. PubMed ID: 21823170
[TBL] [Abstract][Full Text] [Related]
10. Behavioral and quality-of-life outcomes in different service models for methadone maintenance treatment in Vietnam.
Tran BX; Nguyen LH; Nong VM; Nguyen CT; Phan HT; Latkin CA
Harm Reduct J; 2016 Feb; 13():4. PubMed ID: 26837193
[TBL] [Abstract][Full Text] [Related]
11. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel.
Peles E; Schreiber S; Adelson M
Drug Alcohol Depend; 2010 Mar; 107(2-3):141-8. PubMed ID: 19914783
[TBL] [Abstract][Full Text] [Related]
12. Sociodemographic characteristics of patients with children in a methadone maintenance program: a cross-sectional study.
Luo C; Sanger N; Zielinski L; Bhatt M; Shahid H; Shams I; Mouravska N; Luetam S; Hudson J; Thabane L; Samaan Z
Harm Reduct J; 2019 Feb; 16(1):13. PubMed ID: 30744638
[TBL] [Abstract][Full Text] [Related]
13. Patient satisfaction with methadone maintenance treatment: the relevance of participation in treatment and social functioning.
Trujols J; Garijo I; Siñol N; del Pozo J; Portella MJ; Pérez de los Cobos J
Drug Alcohol Depend; 2012 Jun; 123(1-3):41-7. PubMed ID: 22071121
[TBL] [Abstract][Full Text] [Related]
14. The first 38 methadone maintenance treatment patients in Stockholm: 15-year follow-up with a main focus on detoxification from methadone.
Hiltunen AJ; Eklund C; Borg S
Nord J Psychiatry; 2011 Apr; 65(2):106-11. PubMed ID: 20662685
[TBL] [Abstract][Full Text] [Related]
15. Elevated methylation and decreased serum concentrations of BDNF in patients in levomethadone compared to diamorphine maintenance treatment.
Schuster R; Kleimann A; Rehme MK; Taschner L; Glahn A; Groh A; Frieling H; Lichtinghagen R; Hillemacher T; Bleich S; Heberlein A
Eur Arch Psychiatry Clin Neurosci; 2017 Feb; 267(1):33-40. PubMed ID: 26801497
[TBL] [Abstract][Full Text] [Related]
16. Duration of methadone maintenance treatment during pregnancy and pregnancy outcome parameters in women with opiate addiction.
Peles E; Schreiber S; Bloch M; Dollberg S; Adelson M
J Addict Med; 2012 Mar; 6(1):18-23. PubMed ID: 21817914
[TBL] [Abstract][Full Text] [Related]
17. Illicit Heroin and Methamphetamine Use among Methadone Maintenance Treatment Patients in Dehong Prefecture of Yunnan Province, China.
Wang R; Ding Y; Bai H; Duan S; Ye R; Yang Y; Wang J; Tang R; Gao M; He N
PLoS One; 2015; 10(7):e0133431. PubMed ID: 26196394
[TBL] [Abstract][Full Text] [Related]
18. Methadone maintenance treatment may improve completion rates and delay opioid relapse for opioid dependent individuals under community corrections supervision.
Clark CB; Hendricks PS; Lane PS; Trent L; Cropsey KL
Addict Behav; 2014 Dec; 39(12):1736-40. PubMed ID: 25117851
[TBL] [Abstract][Full Text] [Related]
19. Side effects of levomethadone and racemic methadone in a maintenance program.
Judson BA; Horns WH; Goldstein A
Clin Pharmacol Ther; 1976 Oct; 20(4):445-9. PubMed ID: 788990
[TBL] [Abstract][Full Text] [Related]
20. The effects of racemic D,L-methadone and L-methadone in substituted patients--a randomized controlled study.
Verthein U; Ullmann R; Lachmann A; Düring A; Koch B; Meyer-Thompson HG; Schmidt R; Reimer J; Haasen C
Drug Alcohol Depend; 2005 Nov; 80(2):267-71. PubMed ID: 15916866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
